Mannkind Is Having Increased Momentum and Volatiliy in January----This was the title before the stock was rejected by the FDA and the stock has declined considerably

Biotech and Pharmaceutical news:  Mannkind (MNKD)

Google Finance:  MNKD
Mannkind Corp.  Website
Mannkind Pipeline

I am cautious about Mannkind's approval chances with the FDA in the next coming weeks (FDA delayed Dec 29th decision 4 weeks) but I am optimistic about its chances of an increase in stock price while the FDA reviews Mannkind's approval for Afrezza for Diabetes.  Here are some news that has occurred for Mannkind in the past few weeks.  Continued